GC65023
CTX-712
Also known as 2-[(1R)-1-fluoroethyl]-5-[[6-(4-methoxypyrrolo[2,1-f][1,2,4]triazin-5-yl)-2-methylimidazo[4,5-b]pyridin-1-yl]methyl]-1,3,4-oxadiazole
CTX-712 is a potent inhibitor of cdc2-like kinase (CLK)· CTX-712 inhibits CLK kinase activity, and thus inhibits cancer survival and cancer cell growth· CTX-712 has the potential for the research of cancer disease (extracted from patent JPWO2017188374A1, compound 286)
ChemicalCAS2144751-78-8MW408.39FormulaC19H17FN8O2
- CAS number
- 2144751-78-8
- Molecular weight
- 408.39
- Formula
- C19H17FN8O2
- InChIKey
- OENNTZBJPRRGFL-SNVBAGLBSA-N
- Catalogue number
- GC65023
- Brand
- GLPBIO
Computed properties PubChem CID 138522180 · XLogP 1.6 · TPSA 109 Ų · H-bond donors 0
- XLogP
- 1.6
- TPSA
- 109 Ų
- H-bond donors
- 0
- H-bond acceptors
- 9
- Rotatable bonds
- 5
- Heavy atoms
- 30
SMILES CC1=NC2=C(N1CC3=NN=C(O3)[C@@H](C)F)C=C(C=N2)C4=C5C(=NC=NN5C=C4)OC
Computed descriptors from PubChem (CID 138522180), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il